The global cervical cancer treatment market is estimated to grow at a CAGR of nearly 6.0% during the forecast period. The significant prevalence of cervical cancer and government initiatives for prevention, diagnosis, and treatment of cancer disorders that affects women are the major factors driving the growth of the market.